PubRank

Emina Halilbasic

Author PubWeight™ 26.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology 2011 2.67
2 CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 2005 2.45
3 Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 2009 1.87
4 Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology 2013 1.71
5 Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 2005 1.64
6 Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice. Liver Int 2008 1.52
7 Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Med Wochenschr 2008 1.13
8 Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2011 1.04
9 Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Hepatology 2014 0.99
10 SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology 2014 0.96
11 Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011 0.93
12 Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology 2012 0.90
13 Differential effects of norUDCA and UDCA in obstructive cholestasis in mice. J Hepatol 2013 0.88
14 Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment. Dig Dis 2012 0.86
15 New insights into autoimmune cholangitis through animal models. Dig Dis 2010 0.80
16 Mechanisms and functional consequences of liver failure substantially differ between endotoxaemia and faecal peritonitis in rats. Liver Int 2012 0.80
17 Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liver. Eur Radiol 2015 0.80
18 Targeting nuclear bile acid receptors for liver disease. Dig Dis 2011 0.79
19 The role of canalicular ABC transporters in cholestasis. Drug Metab Dispos 2014 0.78
20 Therapy of Primary Sclerosing Cholangitis - Today and Tomorrow. Dig Dis 2015 0.77
21 Fibrate treatment for primary biliary cirrhosis. Curr Opin Gastroenterol 2014 0.77
22 Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies. Dig Dis 2014 0.77
23 Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders. Dig Dis 2015 0.76
24 Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Dig Dis 2015 0.76